I'd imagine it's very hard to forecast.Large regions...

I'd imagine it's very hard to forecast.

Large regions of America are returning to normal with vaccine rates being what they are, but other regions are getting slammed by delta.

I would love an official forecast as well. But they've given us all the information we need to make the forecast ourselves.

Growth trajectory? Solid

Market penetration? 70% UK burns centres? Major GPOs in the states, soon to potentially sign more? 92% of customers purchased at least once? And customers traditionally become repeat customers.

Margins? Already stellar and yet still increasing.

Sales staff? Total staff? Increasing in huge amounts, yet still profitable.

Chronic wounds study? Preliminary results show success. Just wait for approval for Medicare rebates. Insurers will be pushing for the cheaper, better option.

Hernia? Ongoing studies, mostly elective surgeries, good time to take our time and do it right when electives are less affected (hopefully).

I would not be betting against this company, that's for sure